Impaired neuronal migration and endochondral ossification in Pex7 knockout mice: A model for rhizomelic chondrodysplasia punctata

Human Molecular Genetics

Volumn 12, Issue 18, 2003, Pages 2255-2267

  Brites, Pedro ^a   Motley, Alison M ^a,e   Gressens, Pierre ^b   Mooyer, Petra A W ^a   Ploegaert, Ingrid ^a   Everts, Vincent ^a   Evrard, Philippe ^b   Carmeliet, Peter ^c   Dewerchin, Mieke ^c   Schoonjans, Luc ^f   Duran, Marinus ^a   Waterham, Hans R ^a   Wanders, Ronald J A ^a   Baes, Myriam ^d  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e ADDENBROOKE S HOSPITAL   (United Kingdom)

^f Clinical Biochemistry Lab52 ^*

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROXYACETONE PHOSPHATE ACYLTRANSFERASE; PEROXIN; PHYTANIC ACID; PLASMALOGEN; VERY LONG CHAIN FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AUTOSOMAL RECESSIVE DISORDER; BONE DEVELOPMENT; BONE MALFORMATION; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN MALFORMATION; CELL DENSITY; CELL MIGRATION; CHONDRODYSPLASIA PUNCTATA; CLINICAL FEATURE; CONTROLLED STUDY; ENCHONDRAL OSSIFICATION; ENZYME DEFICIENCY; EYE MALFORMATION; FATTY ACID OXIDATION; GENE MUTATION; GROWTH RETARDATION; KNOCKOUT MOUSE; MOUSE; MUSCLE HYPOTONIA; NERVE CELL; NEWBORN; NONHUMAN; PATHOGENESIS; PERINATAL MORTALITY; PEROXISOME; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SKULL; VERTEBRA;

ACETYL-COA C-ACETYLTRANSFERASE; ANIMALS; ANIMALS, NEWBORN; BRAIN; CELL MOVEMENT; CELLS, CULTURED; CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC; DIET; FIBROBLASTS; GENE TARGETING; LIVER; MICE; MICE, KNOCKOUT; MUTATION; NEURONS; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; OXIDATION-REDUCTION; PEROXISOMES; PHYTANIC ACID; PHYTOL; PLASMALOGENS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TIME FACTORS;

ANIMALIA;

EID: 10744225661     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddg236     Document Type: Review

References (88)

1. Wanders, R.J. (2000) Peroxisomes, lipid metabolism, and human disease. Cell Biochem. Biophys., 32, 89-106.
2. Gould, S.J. and Valle, D. (2000) Peroxisome biogenesis disorders: genetics and cell biology. Trends Genet., 16, 340-345.
3. Gould, S.J., Keller, G.A., Hosken, N., Wilkinson, J. and Subramani, S. (1989) A conserved tripeptide sorts proteins to peroxisomes. J. Cell. Biol., 108, 1657-1664.
4. Mullen, R.T., Lee, M.S., Flynn, C.R. and Trelease, R.N. (1997) Diverse amino acid residues function within the type 1 peroxisomal targeting signal. Implications for the role of accessory residues upstream of the type 1 peroxisomal targeting signal. Plant Physiol., 115, 881-889.
5. Swinkels, B.W., Gould, S.J., Bodnar, A.G., Rachubinski, R.A. and Subramani, S. (1991) A novel, cleavable peroxisomal targeting signal at the amino-terminus of the rat 3-ketoacyl-CoA thiolase. EMBO J., 10, 3255-3262.
6. Tsukamoto, T., Hata, S., Yokota, S., Miura, S., Fujiki, Y., Hijikata, M., Miyazawa, S., Hashimoto, T. and Osumi, T. (1994) Characterization of the signal peptide at the amino terminus of the rat peroxisomal 3-ketoacyl-CoA thiolase precursor. J. Biol. Chem., 269, 6001-6010.
7. Legakis, J.E. and Terlecky, S.R. (2001) PTS2 protein import into mammalian peroxisomes. Traffic, 2, 252-260.
8. Subramani, S., Koller, A. and Snyder, W.B. (2000) Import of peroxisomal matrix and membrane proteins. A. Rev. Biochem., 69, 399-418.
9. Subramani, S. (1998) Components involved in peroxisome import, biogenesis, proliferation, turnover, and movement. Physiol. Rev., 78, 171-188.
10. Fransen, M., Terlecky, S.R. and Subramani, S. (1998) Identification of a human PTS1 receptor docking protein directly required for peroxisomal protein import. Proc. Natl Acad. Sci. USA, 95, 8087-8092.
11. Purdue, P.E., Zhang, J.W., Skoneczny, M. and Lazarow, P.B. (1997) Rhizomelic chondrodysplasia punctata is caused by deficiency of human PEX7, a homologue of the yeast PTS2 receptor. Nat. Genet., 15, 381-384.
12. Motley, A.M., Hettema, E.H., Hogenhout, E.M., Brites, P., ten Asbroek, A.L., Wijburg, F.A., Baas, F., Heijmans, H.S., Tabak, H.F., Wanders, R.J. et al. (1997) Rhizomelic chondrodysplasia punctata is a peroxisomal protein targeting disease caused by a non-functional PTS2 receptor. Nat. Genet., 15, 377-380.
13. Braverman, N., Steel, G., Obie, C., Moser, A., Moser, H., Gould, S.J. and Valle, D. (1997) Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata. Nat. Genet., 15, 369-376.
14. Matsumura, T., Otera, H. and Fujiki, Y. (2000) Disruption of the interaction of the longer isoform of Pex5p, Pex5pL, with Pex7p abolishes peroxisome targeting signal type 2 protein import in mammals. Study with a novel Pex5-impaired Chinese hamster ovary cell mutant. J. Biol. Chem., 275, 21715-21721.
15. Otera, H., Harano, T., Honsho, M., Ghaedi, K., Mukai, S., Tanaka, A., Kawai, A., Shimizu, N. and Fujiki, Y. (2000) The mammalian peroxin Pex5pL, the longer isoform of the mobile peroxisome targeting signal (PTS) type 1 transporter, translocates the Pex7p.PTS2 protein complex into peroxisomes via its initial docking site, Pex14p. J. Biol. Chem., 275, 21703-21714.
16. Braverman, N., Dodt, G., Gould, S.J. and Valle, D. (1998) An isoform of pex5p, the human PTS1 receptor, is required for the import of PTS2 proteins into peroxisomes. Hum. Mol. Genet., 7, 1195-1205.
17. Fujiki, Y., Okumoto, K., Otera, H. and Tamura, S. (2000) Peroxisome biogenesis and molecular defects in peroxisome assembly disorders. Cell. Biochem. Biophys., 32, 155-164.
18. Fujiki, Y. (2000) Peroxisome biogenesis and peroxisome biogenesis disorders. FEBS Lett., 476, 42-46.
19. Moser, H.W. (2000) Molecular genetics of peroxisomal disorders. Front. Biosci., 5, D298-306.
20. Moser, H.W. (1999) Peroxisomal disorders. Molecular defects, genotype-phenotype correlations and therapy. J. Med. Liban., 47, 18-21.
21. Heymans, H.S., Oorthuys, J.W., Nelck, G., Wanders, R.J. and Schutgens, R.B. (1985) Rhizomelic chondrodysplasia punctata: another peroxisomal disorder. New Engl. J. Med., 313, 187-188.
22. Agamanolis, D.P. and Novak, R.W. (1995) Rhizomelic chondrodysplasia punctata: report of a case with review of the literature and correlation with other peroxisomal disorders. Pediatr. Pathol. Lab. Med., 15, 503-513.
23. Braverman, N., Chen, L., Lin, P., Obie, C., Steel, G., Douglas, P., Chakraborty, P.K., Clarke, J.T., Boneh, A., Moser, A. et al. (2002) Mutation analysis of PEX7 in 60 probands with rhizomelic chondrodysplasia punctata and functional correlations of genotype with phenotype. Hum. Mutat., 20, 284-297.
24. Motley, A.M., Tabak, H.F., Smeitink, J.A., Poll-The, B.T., Barth, P.G. and Wanders, R.J. (1996) Non-rhizomelic and rhizomelic chondrodysplasia punctata within a single complementation group. Biochim. Biophys. Acta, 1315, 153-158.
25. Barth, P.G., Wanders, R.J., Schutgens, R.B. and Staalman, C.R. (1996) Variant rhizomelic chondrodysplasia punctata (RCDP) with normal plasma phytanic acid: clinico-biochemical delineation of a subtype and complementation studies. Am. J. Med. Genet., 62, 164-168.
26. Wardinsky, T.D., Pagon, R.A., Powell, B.R., McGillivray, B., Stephan, M., Zonana, J. and Moser, A. (1990) Rhizomelic chondrodysplasia, punctata and survival beyond one year: a review of the literature and five case reports. Clin. Genet., 38, 84-93.
27. Motley, A.M., Brites, P., Gerez, L., Hogenhout, E., Haasjes, J., Benne, R., Tabak, H.F., Wanders, R.J. and Waterham, H.R. (2002) Mutational spectrum in the PEX7 gene and functional analysis of mutant alleles in 78 patients with rhizomelic chondrodysplasia punctata type 1. Am. J. Hum. Genet., 70, 612-624.
28. Shimozawa, N., Suzuki, Y., Zhang, Z., Miura, K., Matsumoto, A., Nagaya, M., Castillo-Taucher, S. and Kondo, N. (1999) A novel nonsense mutation of the PEX7 gene in a patient with rhizomelic chondrodysplasia punctata. J. Hum. Genet., 44, 123-125.
29. de Vet, E.C. and van den Bosch, H. (2000) Alkyl-dihydroxyacetone-phosphate synthase. Cell. Biochem. Biophys., 32, 117-121.
30. Jansen, G.A., Hogenhout, E.M., Ferdinandusse, S., Waterham, H.R., Ofman, R., Jakobs, C., Skjeldal, O.H. and Wanders, R.J. (2000) Human phytanoyl-CoA hydroxylase: resolution of the gene structure and the molecular basis of Retsum's disease. Hum. Mol. Genet., 9, 1195-1200.
31. Mihalik, S.J., Morrell, J.C., Kim, D., Sacksteder, K.A., Watkins, P.A. and Gould, S.J. (1997) Identification of PAHX, a Refsum disease gene. Nat. Genet., 17, 185-189.
32. Jansen, G.A., Ofman, R., Ferdinandusse, S., Ijlst, L., Muijsers, A.O., Skjeldal, O.H., Stokke, O., Jakobs, C., Besley, G.T., Wraith, J.E. et al. (1997) Refsum disease is caused by mutations in the phytanoyl-CoA hydroxylase gene. Nat. Genet., 17, 190-193.
33. Bout, A., Teunissen, Y., Hashimoto, T., Benne, R. and Tager, J.M. (1988) Nucleotide sequence of human peroxisomal 3-oxoacyl-CoA thiolase. Nucl. Acids Res., 16, 10369.
34. de Vet, E.C., Ijlst, L., Oostheim, W., Dekker, C., Moser, H.W., van Den Bosch, H. and Wanders, R.J. (1999) Ether lipid biosynthesis: alkyl-dihydroxyacetonephosphate synthase protein deficiency leads to reduced dihydroxyacetonephosphate acyltransferase activities. J. Lipid Res., 40, 1998-2003.
35. Wanders, R.J., Smit, W., Heymans, H.S., Schutgens, R.B., Barth, P.G., Schierbeek, H., Smit, G.P., Berger, R., Przyrembel, H., Eggelte, T.A. et al. (1987) Age-related accumulation of phytanic acid in plasma from patients with the cerebro-hepato-renal (Zellweger) syndrome. Clin. Chim. Acta, 166, 45-56.
36. Hoefler, G., Hoefler, S., Watkins, P.A., Chen, W.W., Moser, A., Baldwin, V., McGillivary, B., Charrow, J., Friedman, J.M., Rutledge, L. et al. (1988) Biochemical abnormalities in rhizomelic chondrodysplasia punctata. J. Pediatr., 112, 726-733.
37. Purdue, R.E., Skoneczny, M., Yang, X., Zhang, J.W. and Lazarow, P.B. (1999) Rhizomelic chondrodysplasia punctata, a peroxisomal biogenesis disorder caused by defects in Pex7p, a peroxisomal protein import receptor: a minireview. Neurochem. Res., 24, 581-586.
38. Skarnes, W.C., Moss, J.E., Hurtley, S.M. and Beddington, R.S. (1995) Capturing genes encoding membrane and secreted proteins important for mouse development. Proc. Natl Acad. Sci. USA, 92, 6592-6596.
39. Farooqui, A.A. and Horrocks, L.A. (2001) Plasmalogens: workhorse lipids of membranes in normal and injured neurons and glia. Neuroscientist, 7, 232-245.
40. Leray, C., Cazenave, J.P. and Gachet, C. (2002) Platelet phospholipids are differentially protected against oxidative degradation by plasmalogens. Lipids, 37, 285-290.
41. Perichon, R., Moser, A.B., Wallace, W.C., Cunningham, S.C., Roth, G.S. and Moser, H.W. (1998) Peroxisomal disease cell lines with cellular plasmalogen deficiency have impaired muscarinic cholinergic signal transduction activity and amyloid precursor protein secretion. Biochem. Biophys. Res. Commun., 248, 57-61.
42. Kitajka, K., Puskas, L.G., Zvara, A., Hackler, L. Jr, Barcelo-Coblijn, G., Yeo, Y.K. and Farkas, T. (2002) The role of n-3 polyunsaturated fatty acids in brain: modulation of rat brain gene expression by dietary n-3 fatty acids. Proc. Natl Acad. Sci. USA, 99, 2619-2624.
43. Nagan, N. and Zoeller, R.A. (2001) Plasmalogens: biosynthesis and functions. Prog. Lipid Res., 40, 199-229.
44. Martinez, M. and Mougan, I. (1999) Fatty acid composition of brain glycerophospholipids in peroxisomal disorders. Lipids, 34, 733-740.
45. Kitareewan, S., Burka, L.T., Tomer, K.B., Parker, C.E., Deterding, L.J., Stevens, R.D., Forman, B.M., Mais, D.E., Heyman, R.A., McMorris, T. et al. (1996) Phytol metabolites are circulating dietary factors that activate the nuclear receptor RXR. Mol. Biol. Cell, 7, 1153-1166.
46. Seedorf, U., Raabe, M., Ellinghaus, P., Kannenberg, F., Fobker, M., Engel, T., Denis, S., Wouters, F., Wirtz, K.W., Wanders, R.J. et al. (1998) Defective peroxisomal catabolism of branched fatty acyl coenzyme A in mice lacking the sterol carrier protein-2/sterol carrier protein-x gene function. Genes Dev., 12, 1189-1201.
47. Schutgens, R.B., Bouman, I.W., Nijenhuis, A.A., Wanders, R.J. and Frumau, M.E. (1993) Profiles of very-long-chain fatty acids in plasma, fibroblasts, and blood cells in Zellweger syndrome, X-linked adrenoleukodystrophy, and rhizomelic chondrodysplasia punctata. Clin. Chem., 39, 1632-1637.
48. Wanders, R.J., Vreken, P., Ferdinandusse, S., Jansen, G.A., Waterham, H.R., van Roermund, C.W. and Van Grunsven, E.G. (2001) Peroxisomal fatty acid alpha- and beta-oxidation in humans: enzymology, peroxisomal metabolite transporters and peroxisomal diseases. Biochem. Soc. Trans., 29, 250-267.
49. Huyghe, S., Casteels, M., Janssen, A., Meulders, L., Mannaerts, G.P., Declercq, P.E., Van Veldhoven, P.P. and Baes, M. (2001) Prenatal and postnatal development of peroxisomal lipid-metabolizing pathways in the mouse. Biochem. J., 353, 673-680.
50. Gleeson, J.G. (2001) Neuronal migration disorders. Ment. Retard. Dev. Disabil. Res. Rev., 7, 167-171.
51. Pilz, D., Stoodley, N. and Golden, J.A. (2002) Neuronal migration, cerebral cortical development, and cerebral cortical anomalies. J. Neuropathol. Exp. Neurol., 61, 1-11.
52. Powers, J.M. and Moser, H.W. (1998) Peroxisomal disorders: genotype, phenotype, major neuropathologic lesions, and pathogenesis. Brain Pathol., 8, 101-120.
53. Powers, J.M., Kenjarski, T.P., Moser, A.B. and Moser, H.W. (1999) Cerebellar atrophy in chronic rhizomelic chondrodysplasia punctata: a potential role for phytanic acid and calcium in the death of its Purkinje cells. Acta Neuropathol. (Berl.), 98, 129-134.
54. Faust, P.L., So, H.M., Moser, A. and Moser, H.W. (2001) The peroxisome deficient PEX2 Zellweger mouse: pathologic and biochemical correlates of lipid dysfunction. J. Mol. Neurosci., 16, 289-297.
55. Baes, M., Gressens, P., Baumgart, E., Carmeliet, P., Casteels, M., Fransen, M., Evrard, P., Fahimi, D., Declercq, P.E., Collen, D. et al. (1997) A mouse model for Zellweger syndrome. Nat. Genet., 17, 49-57.
56. Fan, C.Y., Pan, J., Chu, R., Lee, D., Kluckman, K.D., Usuda, N., Singh, I., Yeldandi, A.V., Rao, M.S., Maeda, N. et al. (1996) Targeted disruption of the peroxisomal fatty acyl-CoA oxidase gene: generation of a mouse model of pseudoneonatal adrenoleukodystrophy. Ann. NY Acad. Sci., 804, 530-541.
57. Forss-Petter, S., Werner, H., Berger, J., Lassmann, H., Molzer, B., Schwab, M.H., Bernheimer, H., Zimmermann, F. and Nave, K.A. (1997) Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice. J. Neurosci. Res., 50, 829-843.
58. Lu, J.F., Lawler, A.M., Watkins, P.A., Powers, J.M., Moser, A.B., Moser, H.W. and Smith, K.D. (1997) A mouse model for X-linked adrenoleukodystrophy. Proc. Natl Acad. Sci. USA, 94, 9366-9371.
59. Kobayashi, T., Shinnoh, N., Kondo, A. and Yamada, T. (1997) Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism. Biochem. Biophys. Res. Commun., 232, 631-636.
60. Infante, J.P., Tschanz, C.L., Shaw, N., Michaud, A.L., Lawrence, P. and Brenna, J.T. (2002) Straight-chain acyl-CoA oxidase knockout mouse accumulates extremely long chain fatty acids from alpha-linolenic acid: evidence for runaway carousel-type enzyme kinetics in peroxisomal beta-oxidation diseases. Mol. Genet. Metab., 75, 108-119.
61. Yamada, T., Shinnoh, N., Kondo, A., Uchiyama, A., Shimozawa, N., Kira, J. and Kobayashi, T. (2000) Very-long-chain fatty acid metabolism in adrenoleukodystrophy protein- deficient mice. Cell. Biochem. Biophys., 32, 239-246.
62. Baes, M., Huyghe, S., Carmeliet, P., Declercq, P.E., Collen, D., Mannaerts, G.P. and Van Veldhoven, P.P. (2000) Inactivation of the peroxisomal multifunctional protein-2 in mice impedes the degradation of not only 2-methyl-branched fatty acids and bile acid intermediates but also of very long chain fatty acids. J. Biol. Chem., 275, 16329-16336.
63. Baes, M., Gressens, P., Huyghe, S., De, N.K., Qi, C., Jia, Y., Mannaerts, G.P., Evrard, P., Van, V.P., Declereq, P.E. et al. (2002) The neuronal migration defect in mice with Zellweger syndrome (Pex5 knockout) is not caused by the inactivity of peroxisomal beta-oxidation. J. Neuropathol. Exp. Neurol., 61, 368-374.
64. Li, X., Baumgart, E., Morrell, J.C., Jimenez-Sanchez, G., Valle, D. and Gould, S.J. (2002) PEX11 beta deficiency is lethal and impairs neuronal migration but does not abrogate peroxisome function. Mol. Cell. Biol., 22, 4358-4365.
65. Olsen, B.R., Reginato, A.M. and Wang, W. (2000) Bone development. A. Rev. Cell. Dev. Biol., 16, 191-220.
66. Wells, T.R., Landing, B.H. and Bostwick, F.H. (1992) Studies of vertebral coronal cleft in rhizomelic chondrodysplasia punctata. Pediatr. Pathol., 12, 593-600.
67. De Luca, F., Uyeda, J.A., Mericq, V., Mancilla, E.E., Yanovski, J.A., Barnes, K.M., Zile, M.H. and Baron, J. (2000) Retinoic acid is a potent regulator of growth plate chondrogenesis. Endocrinology, 141, 346-353.
68. Takishita, Y., Hiraiwa, K. and Nagayama, M. (1990) Effect of retinoic acid on proliferation and differentiation of cultured chondrocytes in terminal differentiation. J. Biochem. (Tokyo), 107, 592-596.
69. Boyan, B.D., Sylvia, V.L., Dean, D.D., Del Toro, F. and Schwartz, Z. (2002) Differential regulation of growth plate choondrocytes by 1alpha,25(OH)(2)D(3) and 24R,25-(OH)(2)D(3) involves cell-maturation-specific membrane-receptor-activated phospholipid metabolism. Crit. Rev. Oral Biol. Med., 13, 143-154.
70. Dean, D.D., Boyan, B.D., Schwart, Z., Muniz, O.E., Carreno, M.R., Maeda, S. and Howell, D.S. (2001) Effect of 1alpha,25-dihydroxyvitamin D3 and 24R,25-dihydroxyvitamin D3 on metalloproteinase activity and cell maturation in growth plate cartilage in vivo. Endocrine, 14, 311-323.
71. Chung, U.I., Lanske, B., Lee, K., Li, E. and Kronenberg, H. (1998) The parathyroid hormone/parathyroid hormone-related peptide receptor coordinates endochondral bone development by directly controlling chondrocyte differentiation. Proc. Natl Acad. Sci. USA, 95, 13030-13035.
72. De Luca, F., Barnes, K.M., Uyeda, J.A., De-Levi, S., Abad, V., Palese, T., Mericq, V. and Baron, J. (2001) Regulation of growth plate chondrogenesis by bone morphogenetic protein - 2. Endocrinology, 142, 430-436.
73. Grimsrud, C.D., Romano, P.R., D'Souza, M., Puzas, J.E., Reynolds, P.R., Rosier, R.N. and O'Keefe, R.J. (1999) BMP-6 is an autocrine stimulator of chondrocyte differentiation. J. Bone Miner. Res., 14, 475-482.
74. Braverman, N., Steel, G., Lin, P., Moser, A., Moser, H. and Valle, D. (2000) PEX7 gene structure, alternative transcripts, and evidence for a founder haplotype for the frequent RCDP allele, L292ter. Genomics, 63, 181-192.
75. Mountford, P., Zevnik, B., Duwel, A., Nichols, J., Li, M., Dani, C., Robertson, M., Chambers, I. and Smith, A. (1994) Dicistronic targeting constructs: reporters and modifiers of mammalian gene expression. Proc. Natl Acad. Sci. USA, 91, 4303-4307.
76. Tate, P., Skarnes, W. and Bird, A. (1996) The methyl-CpG binding protein MeCP2 is essential for embryonic development in the mouse. Nat. Genet., 12, 205-208.
77. Jlst, L., Wanders, R.J., Ushikubo, S., Kamijo, T. and Hashimoto, T. (1994) Molecular basis of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: identification of the major disease-causing mutation in the alpha-subunit of the mitochondrial trifunctional protein. Biochim. Biophys. Acta, 1215, 347-350.
78. Sousa, M.M., Du Yan, S., Fernandes, R., Guimaraes, A., Stern, D. and Saraiva, M.J. (2001) Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways. J. Neurosci., 21, 7576-7586.
79. Heikoop, J.C., van Roermund, C.W., Just, W.W., Ofman, R., Schutgens, R.B., Heymans, H.S., Wanders, R.J. and Tager, J.M. (1990) Rhizomelic chondrodysplasia punctata. Deficiency of 3-oxoacyl-coenzyme A thiolase in peroxisomes and impaired processing of the enzyme. J. Clin. Invest., 86, 126-130.
80. Wiemer, E.A., Ofman, R., Middelkoop, E., de Boer, M., Wanders, R.J. and Tager, J.M. (1992) Production and characterisation of monoclonal antibodies against native and disassembled human catalase. J. Immunol. Meth., 151, 165-175.
81. de Vet, E.C., Biermann, J. and van den Bosch, H. (1997) Immunological localization and tissue distribution of alkyldihydroxyacetonephosphate synthase and deficiency of the enzyme in peroxisomal disorders. Eur. J. Biochem., 247, 511-517.
82. Wanders, R.J., Dekker, C., Ofman, R., Schutgens, R.B. and Mooijer, P. (1995) Immunoblot analysis of peroxisomal proteins in liver and fibroblasts from patients. J. Inherit. Metab. Dis., 18 (Suppl. 1), 101-112.
83. Schrakamp, G., Schalkwijk, C.G., Schutgens, R.B., Wanders, R.J., Tager, J.M. and van den Bosch, H. (1988) Plasmalogen biosynthesis in peroxisomal disorders: fatty alcohol versus alkylglycerol precursors. J. Lipid Res., 29, 325-334.
84. Wanders, R.J., Denis, S., Ruiter, J.P., Schutgens, R.B., van Roermund, C.W. and Jacobs, B.S. (1995) Measurement of peroxisomal fatty acid beta-oxidation in cultured human skin fibroblasts. J. Inherit. Metab. Dis., 18, 113-124.
85. Vreken, P., van Lint, A.E., Bootsma, A.H., Overmars, H., Wanders, R.J. and van Gennip, A.H. (1998) Rapid stable isotope dilution analysis of very-long-chain fatty acids, pristanic acid and phytanic acid using gas chromatography-electron impact mass spectrometry. J. Chromatogr. B Biomed. Sci. Applic., 713, 281-287.
86. Dacremont, G. and Vincent, G. (1995) Assay of plasmalogens and polyunsaturated fatty acids (PUFA) in erythrocytes and fibroblasts. J. Inherit. Metab. Dis., 18, 84-89.
87. Gressens, P., Baes, M., Leroux, P., Lombet, A., Van Veldhoven, P., Janssen, A., Vamecq, J., Marret, S. and Evrard, P. (2000) Neuronal migration disorder in Zellweger mice is secondary to glutamate receptor dysfunction. Ann. Neurol., 48, 336-343.
88. McLeod, M.J. (1980) Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red S. Teratology, 22, 299-301.